Trivalent live attenuated influenza-simian immunodeficiency virus vaccines: Efficacy and evolution of cytotoxic T lymphocyte escape in macaques

Journal of Virology

Volumn 87, Issue 8, 2013, Pages 4146-4160

  Reece, Jeanette C ^a   Alcantara, Sheilajen ^a   Gooneratne, Shayarana ^a   Jegaskanda, Sinthujan ^a   Amaresena, Thakshila ^a   Fernandez, Caroline S ^a   Laurie, Karen ^b   Hurt, Aeron ^b   O'Connor, Shelby L ^c   Harris, Max ^c   Petravic, Janka ^d   Martyushev, Alexey ^d   Grimm, Andrew ^d   Davenport, Miles P ^d   Stambas, John ^e   De Rose, Robert ^a   Kent, Stephen J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; INFLUENZA VACCINE; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; FEMALE; GENE MUTATION; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOREGULATION; INFECTION PREVENTION; INFLUENZA VIRUS; LYMPHOCYTE FUNCTION; MACACA; MALE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VIREMIA;

ANIMALS; EPITOPES; FEMALE; GENE PRODUCTS, GAG; IMMUNE EVASION; INFLUENZA VACCINES; MACACA NEMESTRINA; MALE; MUTATION, MISSENSE; ORTHOMYXOVIRIDAE; SAIDS VACCINES; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MACACA; MACACA NEMESTRINA; ORTHOMYXOVIRIDAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84875769478     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02645-12     Document Type: Article

References (55)

1. Haynes BF, Gilbert PB, McElrath MJ, Zolla-Pazner S, Tomaras GD, Alam SM, Evans DT, Montefiori DC, Karnasuta C, Sutthent R, Liao HX, DeVico AL, Lewis GK, Williams C, Pinter A, Fong Y, Janes H, DeCamp A, Huang Y, Rao M, Billings E, Karasavvas N, Robb ML, Ngauy V, de Souza MS, Paris R, Ferrari G, Bailer RT, Soderberg KA, Andrews C, Berman PW, Frahm N, De Rosa SC, Alpert MD, Yates NL, Shen X, Koup RA, Pitisuttithum P, Kaewkungwal J, Nitayaphan S, Rerks-Ngarm S, Michael NL, Kim JH. 2012. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 366:1275-1286.
2. + T-cell responses in rhesus macaques. J. Virol. 84:3699-3706.
3. Borrow P, Lewicki H, Wei X, Horwitz MS, Peffer N, Meyers H, Nelson JA, Gairin JE, Hahn BH, Oldstone MB, Shaw GM. 1997. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3:205-211.
4. Evans DT, O'Connor DH, Jing P, Dzuris JL, Sidney J, da Silva J, Allen TM, Horton H, Venham JE, Rudersdorf RA, Vogel T, Pauza CD, Bontrop RE, DeMars R, Sette A, Hughes AL, Watkins DI. 1999. Virusspecific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat. Med. 5:1270-1276.
5. + T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189:991-998.
6. Matano T, Shibata R, Siemon C, Connors M, Lane HC, Martin MA. 1998. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 72:164-169.
7. + T cells control AIDS virus replication. Nature 491:129-133.
8. Nixon DF, Townsend AR, Elvin JG, Rizza CR, Gallwey J, McMichael AJ. 1988. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336:484-487.
9. + lymphocytes. Science 283:85-860.
10. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, Gilbert PB, Lama JR, Marmor M, Del Rio C, McElrath MJ, Casimiro DR, Gottesdiener KM, Chodakewitz JA, Corey L, Robertson MN. 2008. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372:1881-1893.
11. McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, Defawe OD, Carter DK, Hural J, Akondy R, Buchbinder SP, Robertson MN, Mehrotra DV, Self SG, Corey L, Shiver JW, Casimiro DR. 2008. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 372:1894-1905.
12. Rolland M, Tovanabutra S, deCamp AC, Frahm N, Gilbert PB, Sanders-Buell E, Heath L, Magaret CA, Bose M, Bradfield A, O'Sullivan A, Crossler J, Jones T, Nau M, Wong K, Zhao H, Raugi DN, Sorensen S, Stoddard JN, Maust BS, Deng W, Hural J, Dubey S, Michael NL, Shiver J, Corey L, Li F, Self SG, Kim J, Buchbinder S, Casimiro DR, Robertson MN, Duerr A, McElrath MJ, McCutchan FE, Mullins JI. 2011. Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nat. Med. 17:366-371.
13. + T cell escape-associated compensatory mutations in simian immunodeficiency virus. J. Virol. 85:13088-13096.
14. Dahirel V, Shekhar K, Pereyra F, Miura T, Artyomov M, Talsania S, Allen TM, Altfeld M, Carrington M, Irvine DJ, Walker BD, Chakraborty AK. 2011. Coordinate linkage of HIV evolution reveals regions of immunological vulnerability. Proc. Natl. Acad. Sci. U. S. A. 108: 11530-11535.
15. Friedrich TC, Frye CA, Yant LJ, O'Connor DH, Kriewaldt NA, Benson M, Vojnov L, Dodds EJ, Cullen C, Rudersdorf R, Hughes AL, Wilson N, Watkins DI. 2004. Extraepitopic compensatory substitutions partially restore fitness to simian immunodeficiency virus variants that escape from an immunodominant cytotoxic-T-lymphocyte response. J. Virol. 78: 2581-2585.
16. Huang KH, Goedhals D, Carlson JM, Brockman MA, Mishra S, Brumme ZL, Hickling S, Tang CS, Miura T, Seebregts C, Heckerman D, Ndung'u T, Walker B, Klenerman P, Steyn D, Goulder P, Phillips R, van Vuuren C, Frater J. 2011. Progression to AIDS in South Africa is associated with both reverting and compensatory viral mutations. PLoS One 6:e19018. doi:10.1371/journal.pone.0019018.
17. Kelleher AD, Long C, Holmes EC, Allen RL, Wilson J, Conlon C, Workman C, Shaunak S, Olson K, Goulder P, Brander C, Ogg G, Sullivan JS, Dyer W, Jones I, McMichael AJ, Rowland-Jones S, Phillips RE. 2001. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J. Exp. Med. 193:375-386.
18. + T cell escape during acute simian immunodeficiency virus infection. J. Virol. 86:605-609.
19. Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Cerundolo V, Hurley A, Markowitz M, Ho DD, Nixon DF, McMichael AJ. 1998. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279:2103-2106.
20. Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA. 2002. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296:1439-1443.
21. O'Connor SL, Lhost JJ, Becker EA, Detmer AM, Johnson RC, Macnair CE, Wiseman RW, Karl JA, Greene JM, Burwitz BJ, Bimber BN, Lank SM, Tuscher JJ, Mee ET, Rose NJ, Desrosiers RC, Hughes AL, Friedrich TC, Carrington M, O'Connor DH. 2010. MHC heterozygote advantage in simian immunodeficiency virus-infected Mauritian cynomolgus macaques. Sci. Transl. Med. 2:22ra18.
22. Sexton A, De Rose R, Reece JC, Alcantara S, Loh L, Moffat JM, Laurie K, Hurt A, Doherty PC, Turner SJ, Kent SJ, Stambas J. 2009. Evaluation of recombinant influenza virus-simian immunodeficiency virus vaccines in macaques. J. Virol. 83:7619-7628.
23. Fernandez CS, Reece JC, Saepuloh U, De Rose R, Ishkandriati D, O'Connor DH, Wiseman RW, Kent SJ. 2011. Screening and confirmatory testing of MHC class I alleles in pig-tailed macaques. Immunogenetics. 63:511-521.
24. +-T-cell responses. J. Virol. 79:4329-4339.
25. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. U. S. A. 97:6108-6113.
26. + T cell immunodominance hierarchy determined by antigen dose and precursor frequencies. Proc. Natl. Acad. Sci. U. S. A. 103:994-999.
27. + T cell response. Proc. Natl. Acad. Sci. U. S. A. 100:7235-7240.
28. Garulli B, Meola M, Stillitano MG, Kawaoka Y, Castrucci MR. 2007. Efficient vagina-to-lower respiratory tract immune trafficking in a murine model of influenza A virus infection. Virology 361:274-282.
29. Mathews JD, Chesson JM, McCaw JM, McVernon J. 2009. Understanding influenza transmission, immunity and pandemic threats. Influenza Other Respir. Viruses 3:143-149.
30. Kent SJ, De Rose R, Mokhonov VV, Mokhonova EI, Fernandez CS, Alcantara S, Rollman E, Mason RD, Loh L, Peut V, Reece JC, Wang XJ, Wilson KM, Suhrbier A, Khromykh A. 2008. Evaluation of recombinant Kunjin replicon SIV vaccines for protective efficacy in macaques. Virology 374:528-534.
31. + T-cell loss in SIV infection. Mucosal Immunol. 2:518-526.
32. De Rose R, Mason RD, Loh L, Peut V, Smith MZ, Fernandez CS, Alcantara S, Amarasena T, Reece J, Seddiki N, Kelleher AD, Zaunders J, Kent SJ. 2008. Safety, immunogenicity, and efficacy of peptidepulsed cellular immunotherapy in macaques. J. Med. Primatol 37(Suppl 2):69-78.
33. Loh L, Kent SJ. 2008. Quantification of simian immunodeficiency virus cytotoxic T lymphocyte escape mutant viruses. AIDS Res. Hum. Retrovir. 24:1067-1072.
34. Loh L, Petravic J, Batten CJ, Davenport MP, Kent SJ. 2008. Vaccination and timing influence SIV immune escape viral dynamics in vivo. PLoS Pathog. 4:e12. doi:10.1371/journal.ppat.0040012.
35. Blankenberg D, Gordon A, Von Kuster G, Coraor N, Taylor J, Nekrutenko A. 2010. Manipulation of FASTQ data with Galaxy. Bioinformatics 26:1783-1785.
36. Blankenberg D, Taylor J, Nekrutenko A. 2011. Making whole genome multiple alignments usable for biologists. Bioinformatics (Oxford, England) 27:2426-2428.
37. Blankenberg D, Von Kuster G, Coraor N, Ananda G, Lazarus R, Mangan M, Nekrutenko A, Taylor J. 2010. Galaxy: a web-based genome analysis tool for experimentalists. Curr. Protoc. Mol. Biol. Chapter 19: Unit 19 10 11-21.
38. Kent WJ. 2002. BLAT: the BLAST-like alignment tool. Genome Res. 12: 656-664.
39. Fernandez CS, Stratov I, De Rose R, Walsh K, Dale CJ, Smith MZ, Agy MB, Hu SL, Krebs K, Watkins DI, O'Connor HD, Davenport MP, Kent SJ. 2005. Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost. J. Virol. 79:5721-5731.
40. Jegaskanda S, Reece JC, De Rose R, Stambas J, Sullivan L, Brooks AG, Kent SJ, Sexton A. 2012. Comparison of influenza and SIV specific CD8 T cell responses in macaques. PLoS One 7:e32431. doi:10.1371/journal.pone.0032431.
41. Arthos J, Cicala C, Martinelli E, Macleod K, Van Ryk D, Wei D, Xiao Z, Veenstra TD, Conrad TP, Lempicki RA, McLaughlin S, Pascuccio M, Gopaul R, McNally J, Cruz CC, Censoplano N, Chung E, Reitano KN, Kottilil S, Goode DJ, Fauci AS. 2008. HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells. Nat. Immunol. 9:301-309.
42. +T lymphocytes by attenuated simian immunodeficiency virus. J. Virol. 74:8762-8766.
43. + T lymphocytes to mucosal surfaces following intramuscular vaccination. J. Immunol. 181:4188-4198.
44. Ansari AA, Reimann KA, Mayne AE, Takahashi Y, Stephenson ST, Wang R, Wang X, Li J, Price AA, Little DM, Zaidi M, Lyles R, Villinger F. 2011. Blocking of α4β7 gut-homing integrin during acute infection leads to decreased plasma and gastrointestinal tissue viral loads in simian immunodeficiency virus-infected rhesus macaques. J. Immunol. 186: 1044-1059.
45. + memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection. Mucosal Immunol. 2:439-449.
46. Mason RD, Alcantara S, Peut V, Loh L, Lifson JD, De Rose R, Kent SJ. 2009. Inactivated simian immunodeficiency virus-pulsed autologous fresh blood cells as an immunotherapy strategy. J. Virol. 83:1501-1510. 47. Davenport MP, Loh L, Petravic J, Kent SJ. 2008. Rates of HIV immune escape and reversion: implications for vaccination. Trends Microbiol. 16: 561-566.
47. Davenport MP, Loh L, Petravic J, Kent SJ. 2008. Rates of HIV immune escape and reversion: implications for vaccination. Trends Microbiol. 16: 561-566.
48. Fernandez CS, Smith MZ, Batten CJ, De Rose R, Reece JC, Rollman E, Venturi V, Davenport MP, Kent SJ. 2007. Vaccine-induced T cells control reversion of AIDS virus immune escape mutants. J. Virol. 81:413-4144.
49. + target cell availability determines the dynamics of immune escape and reversion in vivo. J. Virol. 82:4091-4101.
50. Liu J, O'Brien KL, Lynch DM, Simmons NL, La Porte A, Riggs AM, Abbink P, Coffey RT, Grandpre LE, Seaman MS, Landucci G, Forthal DN, Montefiori DC, Carville A, Mansfield KG, Havenga MJ, Pau MG, Goudsmit J, Barouch DH. 2009. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457:87-91.
51. Hel Z, Tsai WP, Tryniszewska E, Nacsa J, Markham PD, Lewis MG, Pavlakis GN, Felber BK, Tartaglia J, Franchini G. 2006. Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genes. J. Immunol. 176:85-96.
52. Rollman E, Mason RD, Lin J, Brooks AG, Kent SJ. 2008. Protection afforded by live attenuated SIV is associated with rapid killing kinetics of CTLs. J. Med. Primatol 37(Suppl 2):24-32.
53. Krammer F, Pontiller J, Tauer C, Palmberger D, Maccani A, Baumann M, Grabherr R. 2010. Evaluation of the influenza A replicon for transient expression of recombinant proteins in mammalian cells. PLoS One 5:e13265. doi:10.1371/journal.pone.0013265.
54. Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, Pulendran B, Garcia-Sastre A. 2010. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc. Natl. Acad. Sci. U. S. A. 107:11531-11536.
55. Reece JC, Loh L, Alcantara S, Fernandez CS, Stambas J, Sexton A, De Rose R, Petravic J, Davenport MP, Kent SJ. 2010. Timing of immune escape linked to success or failure of vaccination. PLoS One 5:e12774. doi:10.1371/journal.pone.0012774.